These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21950359)

  • 1. Pregnancy under everolimus-based immunosuppression.
    Veroux M; Corona D; Veroux P
    Transpl Int; 2011 Dec; 24(12):e115-7. PubMed ID: 21950359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus used during pregnancy in a living related renal transplant recipient: a case report.
    Chu SH; Liu KL; Chiang YJ; Wang HH; Lai PC
    Transplant Proc; 2008 Sep; 40(7):2446-8. PubMed ID: 18790264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation.
    Framarino dei Malatesta M; Corona LE; De Luca L; Rocca B; Manzia TM; Orlando G; Tisone G; Iaria G
    Transplantation; 2011 May; 91(9):e69-71. PubMed ID: 21508801
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy in a kidney transplant patient treated with everolimus.
    Carta P; Caroti L; Zanazzi M
    Am J Kidney Dis; 2012 Aug; 60(2):329. PubMed ID: 22805522
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal function outcomes in kidney transplant recipients after conversion to everolimus-based immunosuppression regimen with CNI reduction or elimination.
    Cataneo-Dávila A; Zúñiga-Varga J; Correa-Rotter R; Alberú J
    Transplant Proc; 2009 Dec; 41(10):4138-46. PubMed ID: 20005355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of teratogenicity of sirolimus used during early pregnancy in a liver transplant recipient.
    Jankowska I; Oldakowska-Jedynak U; Jabiry-Zieniewicz Z; Cyganek A; Pawlowska J; Teisseyre M; Kalicinski P; Markiewicz M; Paczek L; Socha J
    Transplant Proc; 2004 Dec; 36(10):3232-3. PubMed ID: 15686735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
    Armenti VT; Radomski JS; Moritz MJ; Gaughan WJ; Philips LZ; McGrory CH; Coscia LA;
    Clin Transpl; 2002; ():121-30. PubMed ID: 12971441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk?
    Farsetti S; Zanazzi M; Caroti L; Rosso G; Larti A; Marcucci R; Fedi S; Rogolino A; Cellai AP; Abbate R; Bertoni E; Salvadori M
    Transplant Proc; 2010 May; 42(4):1381-2. PubMed ID: 20534308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
    Armenti VT; Radomski JS; Moritz MJ; Philips LZ; McGrory CH; Coscia LA
    Clin Transpl; 2000; ():123-34. PubMed ID: 11512306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: a case report.
    Margoles HR; Gomez-Lobo V; Veis JH; Sherman MJ; Moore J
    Transplant Proc; 2014; 46(1):281-3. PubMed ID: 24507068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus as basic immunosuppression in pregnancy after renal transplantation. A single-center experience.
    Garcia-Donaire JA; Acevedo M; Gutiérrez MJ; Manzanera MJ; Oliva E; Gutiérrez E; Andrés A; Morales JM
    Transplant Proc; 2005 Nov; 37(9):3754-5. PubMed ID: 16386528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series.
    Lovric S; Kielstein JT; Kayser D; Bröcker V; Becker JU; Hiss M; Schiffer M; Sommerwerck U; Haller H; Strüber M; Welte T; Gottlieb J
    Nephrol Dial Transplant; 2011 Sep; 26(9):3032-8. PubMed ID: 21310739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of kidney transplantation with cyclosporine- and everolimus-based immunosuppression.
    Iaria G; Pisani F; Iorio B; Lucchesi C; De Luca L; Ielpo B; D'Andria D; Tariciotti L; Tisone G
    Transplant Proc; 2006 May; 38(4):1018-9. PubMed ID: 16757249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up.
    Rothenburger M; Teerling E; Bruch C; Lehmkuhl H; Suwelack B; Bara C; Wichter T; Hinder F; Schmid C; Stypmann J
    J Heart Lung Transplant; 2007 Mar; 26(3):250-7. PubMed ID: 17346627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
    Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
    Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
    Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.